| Autor: |
Lemiere C; CIUSS du Nord de l'île de Montréal, Université de Montréal, Montréal, Québec, Canada. Electronic address: catherine.lemiere@umontreal.ca., Martin JG; McGill University Health Centre Research Institute and McGill University, Montréal, Québec, Canada. |
| Jazyk: |
angličtina |
| Zdroj: |
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Aug; Vol. 154 (2), pp. 280-281. Date of Electronic Publication: 2024 Apr 23. |
| DOI: |
10.1016/j.jaci.2024.04.013 |
| Abstrakt: |
Competing Interests: Disclosure statement Disclosure of potential conflicts of interest: C. Lemiere reports having received personal fees from GlaxoSmithKline, AstraZeneca, and Sanofi Genzyme for her participation to advisory boards and to continued medical education unrelated to the submitted work. J. G. Martin is in receipt of funding from AstraZeneca for an observational study of asthma exacerbations. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect